These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 890495

  • 41. Neurotransmitters in the mammalian striatum: neuronal circuits and heterogeneity.
    Semba K, Fibiger HC, Vincent SR.
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):386-94. PubMed ID: 2445456
    [Abstract] [Full Text] [Related]

  • 42. Comparison of content with synthesis, uptake and breakdown of GABA in substantia nigra of unoperated, hemitransected and kainate-treated rats.
    Starr M, Kilpatrick I.
    Life Sci; 1981 Nov 30; 29(22):2281-7. PubMed ID: 7321760
    [No Abstract] [Full Text] [Related]

  • 43. Origin of GABA-ergic strio-nigral neurons as studied by kainate-induced lesions.
    Porceddu ML, Morelli M, Del Fiacco M, Di Chiara G.
    Pharmacol Res Commun; 1980 Jul 30; 12(7):695-8. PubMed ID: 7403239
    [No Abstract] [Full Text] [Related]

  • 44. Effects of manipulating pallidal and nigral GABA on striatally-mediated head-turning in the rat [proceedings].
    Crossman AR, Lee LA, Slater P.
    Br J Pharmacol; 1977 Nov 30; 61(3):483P. PubMed ID: 563262
    [No Abstract] [Full Text] [Related]

  • 45. Transmitters for the afferent and efferent systems of the neostriatum and their possible interactions.
    Kim JS.
    Adv Biochem Psychopharmacol; 1978 Nov 30; 19():217-33. PubMed ID: 29447
    [Abstract] [Full Text] [Related]

  • 46. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A, Bruno F, Cattabeni F, Groppetti A, Parenti M, Racagni G.
    Brain Res; 1978 Apr 21; 145(1):180-4. PubMed ID: 205324
    [No Abstract] [Full Text] [Related]

  • 47. A method for the estimation of gamma-aminobutyric acid using gas-liquid chromatography and electron capture detection.
    Pearson JD, Sharman DF.
    J Neurochem; 1975 Jun 21; 24(6):1225-8. PubMed ID: 236359
    [No Abstract] [Full Text] [Related]

  • 48. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD, Manzino L, Sonsalla PK.
    Exp Neurol; 2000 Feb 21; 161(2):638-46. PubMed ID: 10686083
    [Abstract] [Full Text] [Related]

  • 49. Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system.
    Scheel-Krüger J.
    Acta Neurol Scand Suppl; 1986 Feb 21; 107():1-54. PubMed ID: 3014800
    [No Abstract] [Full Text] [Related]

  • 50. Unilateral electrolytic lesions of the substantia nigra cause contralateral circling in rats.
    Schwartz WJ, Gunn RH, Sharp FR, Evarts EV.
    Brain Res; 1976 Mar 26; 105(2):358-61. PubMed ID: 1260449
    [No Abstract] [Full Text] [Related]

  • 51. Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat.
    Agid Y, Guyenet P, Glowinski J, Beaujouan JC, Javoy F.
    Brain Res; 1975 Mar 28; 86(3):488-92. PubMed ID: 1116013
    [No Abstract] [Full Text] [Related]

  • 52. GABA content of discrete brain nuclei and spinal cord of the rat.
    Van der Heyden JA, de Kloet ER, Korf J, Versteeg DH.
    J Neurochem; 1979 Oct 28; 33(4):857-61. PubMed ID: 490160
    [No Abstract] [Full Text] [Related]

  • 53. On the role of ascending catecholaminergic projections in intracranial self-stimulation of the substantia nigra.
    Clavier RM, Fibiger HC.
    Brain Res; 1977 Aug 12; 131(2):271-86. PubMed ID: 890458
    [No Abstract] [Full Text] [Related]

  • 54. Electronic rotameter for quantitative evaluation of rotational behaviour in rats after unilateral lesions of the nigrostriatal dopamine system.
    Kehinde LO, Buraimoh-Igbo LA, Ude OU, Makanjuola RO.
    Med Biol Eng Comput; 1984 Jul 12; 22(4):361-6. PubMed ID: 6748772
    [No Abstract] [Full Text] [Related]

  • 55. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK, Nash JF, Gudelsky GA.
    J Pharmacol Exp Ther; 1995 Jun 12; 273(3):1063-70. PubMed ID: 7791076
    [Abstract] [Full Text] [Related]

  • 56. Lesions of the striatopetal dopamine and serotonin pathways: anatomy and chemistry.
    Poirier LJ, Sourkes TL.
    Pharmacol Ther B; 1976 Jun 12; 2(1):19-27. PubMed ID: 817331
    [No Abstract] [Full Text] [Related]

  • 57. Constraints on inferring neurochemical involvement in behavior.
    Dismukes RK.
    Neurosci Res Program Bull; 1978 Dec 12; 16(4):580-4. PubMed ID: 35765
    [No Abstract] [Full Text] [Related]

  • 58. Spinal cord dopaminergic neurons: evidence for an uncrossed nigrospinal pathway.
    Commissiong JW, Gentleman S, Neff NH.
    Neuropharmacology; 1979 Jun 12; 18(6):565-8. PubMed ID: 481709
    [No Abstract] [Full Text] [Related]

  • 59. [Morphofunctional features of the substantia nigra, its role in brain pathology and the action of pharmacologic substances].
    Arushanian EB.
    Usp Fiziol Nauk; 1979 Jun 12; 10(2):45-72. PubMed ID: 38580
    [No Abstract] [Full Text] [Related]

  • 60. d-Amphetamine-induced depression of central dopamine neurons: evidence for mediation by both autoreceptors and a striato-nigral feedback pathway.
    Bunney BS, Aghajanian GK.
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct 12; 304(3):255-61. PubMed ID: 714182
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.